Partnering to Advance Rheumatology Research

FOREUM funds innovative, high-quality research to improve the lives of people with rheumatic and musculoskeletal diseases (RMDs).

Our Corporate Partners help make this possible. Their support enables us to invest in promising research, address important unmet needs and strengthen the future of rheumatology research.

Corporate Partnership with FOREUM goes beyond funding. Built around four key pillars – visibility, access, input, and engagement – our programme creates opportunities for partners to connect with the FOREUM community and engage more closely with the research we support.

Infographic(opens in new tab)

We are proud to work with commercial and non-commercial organisations that share our commitment to advancing rheumatology research and improving patient outcomes.

Our Relationship with EULAR 

FOREUM is supported by EULAR, the European Alliance of Associations for Rheumatology.  While FOREUM independently defines its strategy, funding priorities and operations, it works in close coordination with EULAR to maximise the impact of research investment and make the best use of available resources. 

 


 

Our Corporate Partners 

We grateful acknowledge the organisations whose support and unrestricted grants help make FOREUM’s work possible. (+ updated logos) 

Platinum

eular_logo_2021
ucb

Gold

abbvie
j_and_j
novartis
pfizer_logo_color_rgb

Silver

boehringeringelheim
gsk__signal

Bronze

Eli_Lilly_logo_250x250_white
Argenx 250x250px